- Home
- REKR vs CHRS Comparison
REKR vs CHRS Comparison
Compare REKR & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REKR
- CHRS
- Stock Information
- Founded
- REKR 2017
- CHRS 2010
- Country
- REKR United States
- CHRS United States
- Employees
- REKR N/A
- CHRS N/A
- Industry
- REKR Telecommunications Equipment
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- REKR Telecommunications
- CHRS Health Care
- Exchange
- REKR Nasdaq
- CHRS Nasdaq
- Market Cap
- REKR 115.1M
- CHRS 122.9M
- IPO Year
- REKR N/A
- CHRS 2014
- Fundamental
- Price
- REKR $0.98
- CHRS $1.03
- Analyst Decision
- REKR
- CHRS Strong Buy
- Analyst Count
- REKR 0
- CHRS 4
- Target Price
- REKR N/A
- CHRS $5.26
- AVG Volume (30 Days)
- REKR 3.8M
- CHRS 1.9M
- Earning Date
- REKR 05-14-2025
- CHRS 05-08-2025
- Dividend Yield
- REKR N/A
- CHRS N/A
- EPS Growth
- REKR N/A
- CHRS N/A
- EPS
- REKR N/A
- CHRS 0.25
- Revenue
- REKR $46,028,000.00
- CHRS $266,959,999.00
- Revenue This Year
- REKR $14.53
- CHRS N/A
- Revenue Next Year
- REKR $17.91
- CHRS $9.02
- P/E Ratio
- REKR N/A
- CHRS $4.06
- Revenue Growth
- REKR 31.76
- CHRS 3.78
- 52 Week Low
- REKR $0.62
- CHRS $0.66
- 52 Week High
- REKR $2.67
- CHRS $2.43
- Technical
- Relative Strength Index (RSI)
- REKR 54.05
- CHRS 53.99
- Support Level
- REKR $0.73
- CHRS $0.72
- Resistance Level
- REKR $0.85
- CHRS $1.16
- Average True Range (ATR)
- REKR 0.08
- CHRS 0.10
- MACD
- REKR 0.04
- CHRS 0.02
- Stochastic Oscillator
- REKR 86.58
- CHRS 70.18
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which the majority of its revenue comes from the United States.
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.